Involvement of Leptin and Interleukin-1 Signaling in Mammary Cancer Progression
瘦素和白细胞介素 1 信号转导参与乳腺癌进展
基本信息
- 批准号:7683860
- 负责人:
- 金额:$ 28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-29 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantApoptoticBreast Cancer CellBreast Cancer PreventionBreast Cancer TreatmentCell ProliferationCellsDataDevelopmentDietEndometrialEpithelial CellsEstradiolFundingGovernmentGrowthHalf-LifeHumanImmunocompetentImmunocompromised HostImplantIn VitroIncidenceIndividualInterleukin-1InvestigationKnowledgeLaboratoriesLeptinLinkLuciferasesMammary NeoplasmsMammary glandMeasuresMediatingMitosisModelingMusNeoplasm MetastasisObesityPeptide ReceptorPhosphotransferasesPostmenopausePreventionPublishingRapid Access to Intervention DevelopmentRattusRegulationRelative (related person)ReporterResearchResearch DesignRodent ModelRoleSP1 geneSecureSignal PathwaySignal TransductionSmall Interfering RNASystemTestingTranscription Factor AP-1Tumor-DerivedUp-RegulationVascular Endothelial Growth FactorsWomananakinraangiogenesiscancer cellin vivoinhibitor/antagonistinnovationkinase inhibitorleptin receptormalignant breast neoplasmmouse modelnovel therapeuticspromotertranscription factortumor progression
项目摘要
DESCRIPTION (provided by applicant): Despite accumulating evidence suggesting a positive correlation between leptin levels, obesity, post-menopause and breast cancer incidence, our current knowledge on the mechanisms involved in these relationships is still incomplete. Our preliminary data show that specific leptin-induced signaling pathways are involved in the increased levels of factors related to angiogenesis and mitosis in syngeneic immuno-competent mouse models of mammary tumors (MT). The inhibition of leptin signaling in vitro and in vivo by our innovative leptin peptide receptor antagonists (LPrA) significantly reduced establishment and growth of MT and simultaneously decreased the levels of VEGF/VEGFR2. Specific cross-talk between leptin and IL-1 signaling found in endometrial and mammary cancer cells could be involved in their pro-angiogenic and anti-apoptotic effects.
It is hypothesized that the leptin-induced effects on mammary cancer could occur upon leptin signaling the activation of Akt1/NFkB and an increased expression of VEGF/VEGFR2 and bcl-2, which may be linked to, or regulated, in part by IL-1 signaling. To test this hypothesis four models will be used in vitro and in vivo: (1) mouse mammary cancer cells implanted in syngeneic immuno-competent mice; (2) human breast cancer cells (responsive and irresponsive to estradiol) implanted in immuno-compromised mice; (3) human mammary epithelial cells treated with a carcinogenic agent (DMBA); (4) DMBA-MT induced in rats. The impact of leptin levels in establishment/ progression of MT in these rodent models will carefully be examined. To determine the effects of specific leptin-induced signaling pathways, kinase inhibitors, siRNAs, PEGylated-LPrAs (half-lives, 55h) will be used. Luciferase-VEGF promoter (mouse and human) and several transcription factor-reporters will be used to investigate leptin's targets in mouse and human mammary cancer cells. IL-1Ra inhibition of IL-1 signaling will serve to determine the impact of leptin/IL-1 signaling crosstalk on MT. This research would expand our limited knowledge on leptin/IL-1 signaling roles in MT and could generate essential data for new therapeutic strategies to target breast cancer, particularly for post-menopausal and obese women. Inhibition of leptin signaling in such instances might serve as a preventative or adjuvant measure.
描述(由申请人提供):尽管越来越多的证据表明瘦素水平、肥胖、绝经后和乳腺癌发病率之间存在正相关,但我们目前对这些关系所涉及的机制的了解仍然不完整。我们的初步数据表明,特异性瘦素诱导的信号通路参与了同基因免疫能力小鼠乳腺肿瘤(MT)模型中血管生成和有丝分裂相关因子水平的升高。我们创新的瘦素肽受体拮抗剂(LPrA)在体外和体内抑制瘦素信号,显著减少MT的建立和生长,同时降低VEGF/VEGFR2的水平。在子宫内膜和乳腺癌细胞中发现瘦素和IL-1信号之间的特异性串扰可能参与其促血管生成和抗凋亡作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruben Rene Gonzalez-Perez其他文献
Ruben Rene Gonzalez-Perez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruben Rene Gonzalez-Perez', 18)}}的其他基金
Novel adjuvant therapy for triple negative breast cancer
三阴性乳腺癌的新型辅助疗法
- 批准号:
8834729 - 财政年份:2015
- 资助金额:
$ 28万 - 项目类别:
Involvement of leptin and interleukin-1 signaling in mammary cancer progression
瘦素和白细胞介素 1 信号传导参与乳腺癌进展
- 批准号:
7814941 - 财政年份:2009
- 资助金额:
$ 28万 - 项目类别:
Involvement of Leptin and Interleukin-1 Signaling in Mammary Cancer Progression
瘦素和白细胞介素 1 信号转导参与乳腺癌进展
- 批准号:
8113237 - 财政年份:2008
- 资助金额:
$ 28万 - 项目类别:
Involvement of Leptin and Interleukin-1 Signaling in Mammary Cancer Progression
瘦素和白细胞介素 1 信号转导参与乳腺癌进展
- 批准号:
8322773 - 财政年份:2008
- 资助金额:
$ 28万 - 项目类别:
Involvement of Leptin and Interleukin-1 Signaling in Mammary Cancer Progression
瘦素和白细胞介素 1 信号转导参与乳腺癌进展
- 批准号:
7901389 - 财政年份:2008
- 资助金额:
$ 28万 - 项目类别:
Involvement of Leptin and Interleukin-1 Signaling in Mammary Cancer Progression
瘦素和白细胞介素 1 信号转导参与乳腺癌进展
- 批准号:
7342275 - 财政年份:2008
- 资助金额:
$ 28万 - 项目类别:
相似海外基金
Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
- 批准号:
10607815 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
- 批准号:
10622209 - 财政年份:2023
- 资助金额:
$ 28万 - 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
- 批准号:
22H03963 - 财政年份:2022
- 资助金额:
$ 28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
- 批准号:
10537709 - 财政年份:2022
- 资助金额:
$ 28万 - 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
- 批准号:
10388929 - 财政年份:2022
- 资助金额:
$ 28万 - 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:
10356565 - 财政年份:2022
- 资助金额:
$ 28万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10708827 - 财政年份:2022
- 资助金额:
$ 28万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10538071 - 财政年份:2022
- 资助金额:
$ 28万 - 项目类别: